TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+12.54%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.14B
AUM Growth
+$2.14B
(+5%)
Cap. Flow
-$122M
Cap. Flow
% of AUM
-5.71%
Top 10 Holdings %
Top 10 Hldgs %
48.86%
Holding
101
New
8
Increased
17
Reduced
23
Closed
9
Top Buys
| 1 |
Biogen
BIIB
|
$47.7M |
| 2 |
SHPG
Shire pic
SHPG
|
$33.6M |
| 3 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$20.5M |
| 4 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
$13.8M |
| 5 |
Ventas
VTR
|
$11.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$38.6M |
| 2 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$32.8M |
| 3 |
Illumina
ILMN
|
$23.2M |
| 4 |
Amgen
AMGN
|
$20.7M |
| 5 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$20.5M |
Sector Composition
| 1 | Healthcare | 85.41% |
| 2 | Real Estate | 4.11% |
| 3 | Financials | 1.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Ventas
VTR
$30.7B
| $21M | 0.98% |
256,389
+136,959
| +115% | +$11.2M |
|
|
GEVA
27
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $20.7M | 0.97% |
223,020
| – | – |
|
|
MDRX
28
DELISTED
Veradigm Inc. Common Stock
MDRX
| $20.5M | 0.96% |
+1,604,600
| New | +$20.5M |
|
|
29
Illumina
ILMN
$15.2B
| $19.2M | 0.9% |
106,749
-129,014
| -55% | -$23.2M |
|
30
Molina Healthcare
MOH
$9.6B
| $18.6M | 0.87% |
347,901
| – | – |
|
|
ENDP
31
DELISTED
Endo International plc
ENDP
| $18.2M | 0.85% |
251,773
-84,442
| -25% | -$6.09M |
|
32
iShares Biotechnology ETF
IBB
$5.68B
| $17.5M | 0.82% |
173,010
-65,115
| -27% | -$6.58M |
|
|
DOC
33
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $15.9M | 0.74% |
958,002
+286,300
| +43% | +$4.75M |
|
34
Thermo Fisher Scientific
TMO
$183B
| $15.2M | 0.71% |
120,995
-145,880
| -55% | -$18.3M |
|
35
Omega Healthcare
OHI
$12.5B
| $14.7M | 0.69% |
376,416
+123,800
| +49% | +$4.84M |
|
36
McKesson
MCK
$85.9B
| $14.1M | 0.66% |
67,862
| – | – |
|
37
Medical Properties Trust
MPW
$2.66B
| $13.5M | 0.63% |
978,774
+351,500
| +56% | +$4.84M |
|
|
WELL.PRI
38
DELISTED
Welltower Inc.
WELL.PRI
| – | – |
0
| – | -$11.4M |
|
39
Eli Lilly
LLY
$661B
| $12.9M | 0.6% |
186,918
| – | – |
|
|
MNTA
40
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $12.9M | 0.6% |
1,067,575
| – | – |
|
41
Sabra Healthcare REIT
SBRA
$4.56B
| $12.4M | 0.58% |
407,890
+64,500
| +19% | +$1.96M |
|
|
EIGR
42
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $11.8M | 0.55% |
1,348
-809
| -38% | -$7.11M |
|
43
Ironwood Pharmaceuticals
IRWD
$201M
| $11.8M | 0.55% |
917,052
| – | – |
|
|
ALR
44
DELISTED
Alere Inc
ALR
| $11.3M | 0.53% |
297,901
| – | – |
|
|
ACOR
45
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $11.2M | 0.52% |
2,276
| – | – |
|
|
IPXL
46
DELISTED
Impax Laboratories, Inc.
IPXL
| $10.9M | 0.51% |
344,683
-645,600
| -65% | -$20.5M |
|
47
HCA Healthcare
HCA
$95.4B
| $10.8M | 0.51% |
147,488
+31,800
| +27% | +$2.33M |
|
48
Perrigo
PRGO
$3.21B
| $10.5M | 0.49% |
62,952
| – | – |
|
49
Verastem
VSTM
$585M
| $10.5M | 0.49% |
95,819
| – | – |
|
50
Sangamo Therapeutics
SGMO
$161M
| $10.3M | 0.48% |
679,100
-71,000
| -9% | -$1.08M |
|